CA Stock MarketDetailed Quotes

HBP Helix BioPharma Corp

Watchlist
  • 0.890
  • -0.040-4.30%
15min DelayMarket Closed Jan 10 16:00 ET
47.19MMarket Cap-0.85P/E (TTM)

Helix BioPharma Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
53.51%-861K
5.56%-5.22M
51.46%-747K
25.13%-1.13M
-36.81%-1.49M
-33.14%-1.85M
15.09%-5.53M
15.35%-1.54M
7.10%-1.5M
20.64%-1.09M
Net income from continuing operations
-6.54%-1.34M
-47.28%-9.26M
-145.03%-5.28M
-36.06%-1.83M
23.88%-902K
21.92%-1.25M
4.16%-6.29M
-55.41%-2.15M
0.00%-1.35M
41.31%-1.19M
Operating gains losses
116.67%2K
1,133.33%31K
133.33%6K
172.73%8K
--29K
-146.15%-12K
-133.33%-3K
-28.57%-18K
---11K
--0
Depreciation and amortization
0.00%4K
7.69%14K
-25.00%3K
33.33%4K
0.00%3K
33.33%4K
8.33%13K
33.33%4K
0.00%3K
0.00%3K
Remuneration paid in stock
82.35%62K
517.75%3.52M
772.22%3.45M
-82.35%6K
-82.93%21K
112.50%34K
33.88%569K
1,031.43%396K
-57.50%34K
-49.80%123K
Other non cashItems
---268K
----
----
----
----
----
----
----
----
----
Change In working capital
208.17%675K
162.16%485K
358.37%1.07M
470.81%686K
-1,854.55%-645K
-467.06%-624K
120.74%185K
150.65%233K
72.75%-185K
-110.61%-33K
-Change in receivables
357.14%18K
-96.31%8K
-33.33%34K
-212.50%-25K
0.00%6K
-104.17%-7K
193.24%217K
-27.14%51K
73.33%-8K
160.00%6K
-Change in prepaid assets
1,105.56%181K
-624.32%-194K
65.00%-7K
-256.56%-191K
-15.38%22K
80.22%-18K
157.81%37K
79.59%-20K
165.22%122K
204.00%26K
-Change in payables and accrued expense
19.30%476K
1,072.46%671K
-33.57%93K
369.62%852K
-4,907.14%-673K
329.03%399K
92.35%-69K
132.41%140K
54.53%-316K
-95.95%14K
-Change in other current liabilities
--0
----
----
194.12%50K
--0
---998K
----
----
--17K
---79K
Cash from discontinued investing activities
Operating cash flow
53.51%-861K
5.56%-5.22M
51.40%-748K
25.20%-1.13M
-36.69%-1.49M
-33.24%-1.85M
15.10%-5.53M
15.39%-1.54M
7.10%-1.5M
20.57%-1.09M
Investing cash flow
Cash flow from continuing investing activities
166.67%8K
-180.00%-14K
-150.00%-2K
0
0
-100.00%-12K
-5K
4K
0
-3K
Net PPE purchase and sale
166.67%8K
-180.00%-14K
-150.00%-2K
--0
--0
-100.00%-12K
---5K
--4K
--0
---3K
Cash from discontinued investing activities
Investing cash flow
166.67%8K
-180.00%-14K
-150.00%-2K
--0
--0
-100.00%-12K
---5K
--4K
--0
---3K
Financing cash flow
Cash flow from continuing financing activities
0
78.36%5.51M
9.82%1.1M
1.72M
100.21%1K
4.64%2.69M
-50.25%3.09M
-68.57%998K
0
-478K
Net issuance payments of debt
----
--0
--0
--0
----
----
---2.06M
--406K
--0
--0
Net common stock issuance
--0
32.64%5.51M
369.95%1.1M
--1.72M
-99.98%1K
561.58%2.69M
38.64%4.15M
-4,411.11%-406K
--0
--4.15M
Net other financing activities
----
----
----
----
----
----
--998K
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
78.36%5.51M
9.82%1.1M
--1.72M
100.21%1K
4.64%2.69M
-50.25%3.09M
-68.57%998K
--0
---478K
Net cash flow
Beginning cash position
33.79%1.08M
-75.15%808K
-46.62%710K
-95.75%120K
-62.68%1.64M
-75.15%808K
-8.78%3.25M
-29.33%1.33M
499.36%2.82M
134.76%4.4M
Current changes in cash
-203.77%-853K
111.17%273K
164.43%346K
139.76%598K
5.15%-1.49M
-29.80%822K
-703.95%-2.44M
-139.60%-537K
-206.59%-1.5M
-14.39%-1.57M
Effect of exchange rate changes
--0
----
----
-172.73%-8K
---28K
142.31%11K
----
----
--11K
--0
End cash Position
-86.11%228K
33.79%1.08M
33.79%1.08M
-46.62%710K
-95.75%120K
-62.68%1.64M
-75.15%808K
-75.15%808K
-29.33%1.33M
499.36%2.82M
Free cash from
53.81%-861K
5.47%-5.23M
51.30%-750K
25.20%-1.13M
-36.31%-1.49M
-33.52%-1.86M
14.95%-5.54M
15.34%-1.54M
7.10%-1.5M
20.35%-1.1M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Oct 31, 2024 (FY)Jul 31, 2024 (Q4)Jul 31, 2024 (Q3)Apr 30, 2024 (Q2)Jan 31, 2024 (Q1)Oct 31, 2023 (FY)Jul 31, 2023 (Q4)Jul 31, 2023 (Q3)Apr 30, 2023 (Q2)Jan 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 53.51%-861K 5.56%-5.22M 51.46%-747K 25.13%-1.13M -36.81%-1.49M -33.14%-1.85M 15.09%-5.53M 15.35%-1.54M 7.10%-1.5M 20.64%-1.09M
Net income from continuing operations -6.54%-1.34M -47.28%-9.26M -145.03%-5.28M -36.06%-1.83M 23.88%-902K 21.92%-1.25M 4.16%-6.29M -55.41%-2.15M 0.00%-1.35M 41.31%-1.19M
Operating gains losses 116.67%2K 1,133.33%31K 133.33%6K 172.73%8K --29K -146.15%-12K -133.33%-3K -28.57%-18K ---11K --0
Depreciation and amortization 0.00%4K 7.69%14K -25.00%3K 33.33%4K 0.00%3K 33.33%4K 8.33%13K 33.33%4K 0.00%3K 0.00%3K
Remuneration paid in stock 82.35%62K 517.75%3.52M 772.22%3.45M -82.35%6K -82.93%21K 112.50%34K 33.88%569K 1,031.43%396K -57.50%34K -49.80%123K
Other non cashItems ---268K ---- ---- ---- ---- ---- ---- ---- ---- ----
Change In working capital 208.17%675K 162.16%485K 358.37%1.07M 470.81%686K -1,854.55%-645K -467.06%-624K 120.74%185K 150.65%233K 72.75%-185K -110.61%-33K
-Change in receivables 357.14%18K -96.31%8K -33.33%34K -212.50%-25K 0.00%6K -104.17%-7K 193.24%217K -27.14%51K 73.33%-8K 160.00%6K
-Change in prepaid assets 1,105.56%181K -624.32%-194K 65.00%-7K -256.56%-191K -15.38%22K 80.22%-18K 157.81%37K 79.59%-20K 165.22%122K 204.00%26K
-Change in payables and accrued expense 19.30%476K 1,072.46%671K -33.57%93K 369.62%852K -4,907.14%-673K 329.03%399K 92.35%-69K 132.41%140K 54.53%-316K -95.95%14K
-Change in other current liabilities --0 ---- ---- 194.12%50K --0 ---998K ---- ---- --17K ---79K
Cash from discontinued investing activities
Operating cash flow 53.51%-861K 5.56%-5.22M 51.40%-748K 25.20%-1.13M -36.69%-1.49M -33.24%-1.85M 15.10%-5.53M 15.39%-1.54M 7.10%-1.5M 20.57%-1.09M
Investing cash flow
Cash flow from continuing investing activities 166.67%8K -180.00%-14K -150.00%-2K 0 0 -100.00%-12K -5K 4K 0 -3K
Net PPE purchase and sale 166.67%8K -180.00%-14K -150.00%-2K --0 --0 -100.00%-12K ---5K --4K --0 ---3K
Cash from discontinued investing activities
Investing cash flow 166.67%8K -180.00%-14K -150.00%-2K --0 --0 -100.00%-12K ---5K --4K --0 ---3K
Financing cash flow
Cash flow from continuing financing activities 0 78.36%5.51M 9.82%1.1M 1.72M 100.21%1K 4.64%2.69M -50.25%3.09M -68.57%998K 0 -478K
Net issuance payments of debt ---- --0 --0 --0 ---- ---- ---2.06M --406K --0 --0
Net common stock issuance --0 32.64%5.51M 369.95%1.1M --1.72M -99.98%1K 561.58%2.69M 38.64%4.15M -4,411.11%-406K --0 --4.15M
Net other financing activities ---- ---- ---- ---- ---- ---- --998K ---- ---- ----
Cash from discontinued financing activities
Financing cash flow --0 78.36%5.51M 9.82%1.1M --1.72M 100.21%1K 4.64%2.69M -50.25%3.09M -68.57%998K --0 ---478K
Net cash flow
Beginning cash position 33.79%1.08M -75.15%808K -46.62%710K -95.75%120K -62.68%1.64M -75.15%808K -8.78%3.25M -29.33%1.33M 499.36%2.82M 134.76%4.4M
Current changes in cash -203.77%-853K 111.17%273K 164.43%346K 139.76%598K 5.15%-1.49M -29.80%822K -703.95%-2.44M -139.60%-537K -206.59%-1.5M -14.39%-1.57M
Effect of exchange rate changes --0 ---- ---- -172.73%-8K ---28K 142.31%11K ---- ---- --11K --0
End cash Position -86.11%228K 33.79%1.08M 33.79%1.08M -46.62%710K -95.75%120K -62.68%1.64M -75.15%808K -75.15%808K -29.33%1.33M 499.36%2.82M
Free cash from 53.81%-861K 5.47%-5.23M 51.30%-750K 25.20%-1.13M -36.31%-1.49M -33.52%-1.86M 14.95%-5.54M 15.34%-1.54M 7.10%-1.5M 20.35%-1.1M
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- Unqualified Opinion -- -- -- -- -- -- -- --

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.